[
    [
        {
            "time": "2019-07-09",
            "original_text": "美年健康(002044.SZ)年报推10派0.531516元 股权登记日7月9日",
            "features": {
                "keywords": [
                    "美年健康",
                    "年报",
                    "分红",
                    "股权登记日"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗",
                    "健康"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "美年健康(002044.SZ)年报推10派0.531516元 股权登记日7月9日",
                "Correlation": 10,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "希玛眼科大涨近35%，医药行业结构性投资机会值得关注",
            "features": {
                "keywords": [
                    "希玛眼科",
                    "大涨",
                    "医药行业",
                    "投资机会"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "希玛眼科大涨近35%，医药行业结构性投资机会值得关注",
                "Correlation": 8,
                "Sentiment": 9,
                "Importance": 8,
                "Impact": 9,
                "Duration": 6,
                "Entity_Density": 7,
                "Market_Scope": 7,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2019-07-02",
            "original_text": "海外医药新闻发布2019/7/2【西南医药朱国广陈铁林团队】",
            "features": {
                "keywords": [
                    "海外医药",
                    "新闻发布",
                    "西南医药",
                    "研究团队"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "false",
                "causal_impact": "",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "海外医药新闻发布2019/7/2【西南医药朱国广陈铁林团队】",
                "Correlation": 5,
                "Sentiment": 5,
                "Importance": 5,
                "Impact": 4,
                "Duration": 5,
                "Entity_Density": 3,
                "Market_Scope": 8,
                "Time_Proximity": 3,
                "Headline_Structure": 5,
                "Source_Recency": 2
            }
        },
        {
            "time": "",
            "original_text": "智飞生物:19H1业绩延续高增长,预防微卡获批在即",
            "features": {
                "keywords": [
                    "智飞生物",
                    "业绩增长",
                    "预防微卡",
                    "获批"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "智飞生物:19H1业绩延续高增长,预防微卡获批在即",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        }
    ]
]